Characterization of TEK receptor tyrosine kinase and its ligands, Angiopoietins, in human hematopoietic progenitor cells

Atsuo Sato, Atsushi Iwama, Nobuyuki Takakura, Hitoshi Nishio, George D. Yancopoulos, Toshio Suda

Research output: Contribution to journalArticle

74 Citations (Scopus)

Abstract

TEK, or TIE-2, is a receptor tyrosine kinase (RTK) that is known as a functioning molecule of vascular endothelial cells. TEK comprises a subfamily of RTK with TIE, and these two receptors play critical roles in vascular maturation, maintenance of integrity and remodeling. We generated mAb against the extracellular domain of human TEK protein to elucidate its expression pattern in human hematopoietic cells. Flow cytometric analysis of bone marrow cells revealed that TEK was expressed in 27% of CD34+ cells, 20% of c-KIT+ cells and 26% of CD34+CD38- cells, indicating that TEK is expressed in a subset of primitive hematopoietic stem cells (HSC). TEK was also expressed in 20% of CD19+ B lymphocytes but not in other lineage-committed cells. Progenitor assays in methylcellulose culture showed that CD34+TEK+ cells formed significantly less BFU-E and CFU-Mix than CD34+TEK- cells, but there was no difference in the number of CFU-GM between these two populations. Two recently identified TEK ligands, termed Angiopoietin-1 and -2, bound to TEK with similar affinities, and Angiopoietin-1 effectively induced TEK phosphorylation in hematopoietic cells. Angiopoietin-2 also induced a low level of TEK phosphorylation and weakened the phosphorylation induced by Angiopoietin-1, suggestive of an elaborate regulator of the TEK-TEK ligand signaling pathway. Although neither ligands affected the proliferation of TEK-transfected hematopoietic cells or the colony formation of CD34+TEK+ bone marrow cells, both promoted the adhesion of TEK-transfected hematopoietic cells to a collagen matrix or a layer of bone marrow stromal cells. These findings indicate that the TEK-TEK ligand signaling pathway is regulated in a refined manner and is involved in hematopoietic cell-microenvironment interaction.

Original languageEnglish
Pages (from-to)1217-1227
Number of pages11
JournalInternational Immunology
Volume10
Issue number8
DOIs
Publication statusPublished - 1998

Fingerprint

Angiopoietins
Receptor Protein-Tyrosine Kinases
Hematopoietic Stem Cells
Ligands
Angiopoietin-1
TIE Receptors
Angiopoietin-2
Phosphorylation
Bone Marrow Cells
Cellular Microenvironment
Granulocyte-Macrophage Progenitor Cells
Erythroid Precursor Cells
Methylcellulose
Mesenchymal Stromal Cells
Cell Communication
Blood Vessels
B-Lymphocytes
Collagen
Endothelial Cells
Maintenance

Keywords

  • Angiopoietins
  • Hematopoietic microenvironment
  • Hematopoietic stem cells
  • TEK-TIE-2 receptor tyrosine kinase

ASJC Scopus subject areas

  • Immunology

Cite this

Characterization of TEK receptor tyrosine kinase and its ligands, Angiopoietins, in human hematopoietic progenitor cells. / Sato, Atsuo; Iwama, Atsushi; Takakura, Nobuyuki; Nishio, Hitoshi; Yancopoulos, George D.; Suda, Toshio.

In: International Immunology, Vol. 10, No. 8, 1998, p. 1217-1227.

Research output: Contribution to journalArticle

Sato, Atsuo ; Iwama, Atsushi ; Takakura, Nobuyuki ; Nishio, Hitoshi ; Yancopoulos, George D. ; Suda, Toshio. / Characterization of TEK receptor tyrosine kinase and its ligands, Angiopoietins, in human hematopoietic progenitor cells. In: International Immunology. 1998 ; Vol. 10, No. 8. pp. 1217-1227.
@article{c3be0b38a81948389409a723a4558658,
title = "Characterization of TEK receptor tyrosine kinase and its ligands, Angiopoietins, in human hematopoietic progenitor cells",
abstract = "TEK, or TIE-2, is a receptor tyrosine kinase (RTK) that is known as a functioning molecule of vascular endothelial cells. TEK comprises a subfamily of RTK with TIE, and these two receptors play critical roles in vascular maturation, maintenance of integrity and remodeling. We generated mAb against the extracellular domain of human TEK protein to elucidate its expression pattern in human hematopoietic cells. Flow cytometric analysis of bone marrow cells revealed that TEK was expressed in 27{\%} of CD34+ cells, 20{\%} of c-KIT+ cells and 26{\%} of CD34+CD38- cells, indicating that TEK is expressed in a subset of primitive hematopoietic stem cells (HSC). TEK was also expressed in 20{\%} of CD19+ B lymphocytes but not in other lineage-committed cells. Progenitor assays in methylcellulose culture showed that CD34+TEK+ cells formed significantly less BFU-E and CFU-Mix than CD34+TEK- cells, but there was no difference in the number of CFU-GM between these two populations. Two recently identified TEK ligands, termed Angiopoietin-1 and -2, bound to TEK with similar affinities, and Angiopoietin-1 effectively induced TEK phosphorylation in hematopoietic cells. Angiopoietin-2 also induced a low level of TEK phosphorylation and weakened the phosphorylation induced by Angiopoietin-1, suggestive of an elaborate regulator of the TEK-TEK ligand signaling pathway. Although neither ligands affected the proliferation of TEK-transfected hematopoietic cells or the colony formation of CD34+TEK+ bone marrow cells, both promoted the adhesion of TEK-transfected hematopoietic cells to a collagen matrix or a layer of bone marrow stromal cells. These findings indicate that the TEK-TEK ligand signaling pathway is regulated in a refined manner and is involved in hematopoietic cell-microenvironment interaction.",
keywords = "Angiopoietins, Hematopoietic microenvironment, Hematopoietic stem cells, TEK-TIE-2 receptor tyrosine kinase",
author = "Atsuo Sato and Atsushi Iwama and Nobuyuki Takakura and Hitoshi Nishio and Yancopoulos, {George D.} and Toshio Suda",
year = "1998",
doi = "10.1093/intimm/10.8.1217",
language = "English",
volume = "10",
pages = "1217--1227",
journal = "International Immunology",
issn = "0953-8178",
publisher = "Oxford University Press",
number = "8",

}

TY - JOUR

T1 - Characterization of TEK receptor tyrosine kinase and its ligands, Angiopoietins, in human hematopoietic progenitor cells

AU - Sato, Atsuo

AU - Iwama, Atsushi

AU - Takakura, Nobuyuki

AU - Nishio, Hitoshi

AU - Yancopoulos, George D.

AU - Suda, Toshio

PY - 1998

Y1 - 1998

N2 - TEK, or TIE-2, is a receptor tyrosine kinase (RTK) that is known as a functioning molecule of vascular endothelial cells. TEK comprises a subfamily of RTK with TIE, and these two receptors play critical roles in vascular maturation, maintenance of integrity and remodeling. We generated mAb against the extracellular domain of human TEK protein to elucidate its expression pattern in human hematopoietic cells. Flow cytometric analysis of bone marrow cells revealed that TEK was expressed in 27% of CD34+ cells, 20% of c-KIT+ cells and 26% of CD34+CD38- cells, indicating that TEK is expressed in a subset of primitive hematopoietic stem cells (HSC). TEK was also expressed in 20% of CD19+ B lymphocytes but not in other lineage-committed cells. Progenitor assays in methylcellulose culture showed that CD34+TEK+ cells formed significantly less BFU-E and CFU-Mix than CD34+TEK- cells, but there was no difference in the number of CFU-GM between these two populations. Two recently identified TEK ligands, termed Angiopoietin-1 and -2, bound to TEK with similar affinities, and Angiopoietin-1 effectively induced TEK phosphorylation in hematopoietic cells. Angiopoietin-2 also induced a low level of TEK phosphorylation and weakened the phosphorylation induced by Angiopoietin-1, suggestive of an elaborate regulator of the TEK-TEK ligand signaling pathway. Although neither ligands affected the proliferation of TEK-transfected hematopoietic cells or the colony formation of CD34+TEK+ bone marrow cells, both promoted the adhesion of TEK-transfected hematopoietic cells to a collagen matrix or a layer of bone marrow stromal cells. These findings indicate that the TEK-TEK ligand signaling pathway is regulated in a refined manner and is involved in hematopoietic cell-microenvironment interaction.

AB - TEK, or TIE-2, is a receptor tyrosine kinase (RTK) that is known as a functioning molecule of vascular endothelial cells. TEK comprises a subfamily of RTK with TIE, and these two receptors play critical roles in vascular maturation, maintenance of integrity and remodeling. We generated mAb against the extracellular domain of human TEK protein to elucidate its expression pattern in human hematopoietic cells. Flow cytometric analysis of bone marrow cells revealed that TEK was expressed in 27% of CD34+ cells, 20% of c-KIT+ cells and 26% of CD34+CD38- cells, indicating that TEK is expressed in a subset of primitive hematopoietic stem cells (HSC). TEK was also expressed in 20% of CD19+ B lymphocytes but not in other lineage-committed cells. Progenitor assays in methylcellulose culture showed that CD34+TEK+ cells formed significantly less BFU-E and CFU-Mix than CD34+TEK- cells, but there was no difference in the number of CFU-GM between these two populations. Two recently identified TEK ligands, termed Angiopoietin-1 and -2, bound to TEK with similar affinities, and Angiopoietin-1 effectively induced TEK phosphorylation in hematopoietic cells. Angiopoietin-2 also induced a low level of TEK phosphorylation and weakened the phosphorylation induced by Angiopoietin-1, suggestive of an elaborate regulator of the TEK-TEK ligand signaling pathway. Although neither ligands affected the proliferation of TEK-transfected hematopoietic cells or the colony formation of CD34+TEK+ bone marrow cells, both promoted the adhesion of TEK-transfected hematopoietic cells to a collagen matrix or a layer of bone marrow stromal cells. These findings indicate that the TEK-TEK ligand signaling pathway is regulated in a refined manner and is involved in hematopoietic cell-microenvironment interaction.

KW - Angiopoietins

KW - Hematopoietic microenvironment

KW - Hematopoietic stem cells

KW - TEK-TIE-2 receptor tyrosine kinase

UR - http://www.scopus.com/inward/record.url?scp=0031903227&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031903227&partnerID=8YFLogxK

U2 - 10.1093/intimm/10.8.1217

DO - 10.1093/intimm/10.8.1217

M3 - Article

C2 - 9723709

AN - SCOPUS:0031903227

VL - 10

SP - 1217

EP - 1227

JO - International Immunology

JF - International Immunology

SN - 0953-8178

IS - 8

ER -